IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE)

Journal of the Neurological Sciences

Volumn 171, Issue 1, 1999, Pages 60-64

  Constantinescu, Cris S ^a   Hilliard, Brendan ^a   Wysocka, Maria ^b   Ventura, Elvira S ^a   Bhopale, Mahendra K ^a   Trinchieri, Giorgio ^b   Rostami, A M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

Autoimmunity; Cytokines; EAE MS; Th1 Th2

Indexed keywords

GLYCOPROTEIN GP 39; INTERLEUKIN 12; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 12;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; CD40 LIGAND; CROSSES, GENETIC; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GUINEA PIGS; IMMUNITY, CELLULAR; IMMUNOSUPPRESSION; INCIDENCE; INTERLEUKIN-12; LIGANDS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; RECOMBINANT PROTEINS; SPINAL CORD;

EID: 0032696945     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00249-X     Document Type: Article

References (42)

1. Grewal I.S., Flavell R.A. The CD40 ligand: at the center of the immune universe? Immunol Res. 16:1997;59-70.
2. Farrington M., Grosmaire L.S., Nonoyama S., Fischer S.H., Hollenbaugh D., Ledbetter J.A., Noelle R.J., Aruffo A., Ochs H.D. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA. 91:1994;1099-1103.
3. Grewal I.S., Xu J., Flavell R.A. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature. 378:1995;617-620.
4. Soong L., Xu J.C., Grewal I.S., Kima P., Sun J., Longley B.J.J., Ruddle N., McMahon-Pratt D., Flavell R.A. Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmamnia amazonensis infection. Immunity. 4:1996;263-273.
5. van Essen D., Kikutani H., Gray D. CD40 ligand-transduced co-stimulation of T cells in the development of helper function. Nature. 378:1995;620.
6. Roy M., Aruffo A., Ledbetter X., Linsley M., Kehry M., Noelle R.J. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur J Immunol. 25:1995;596-603.
7. Shinde S., Wu Y., Guo Y., Niu O., Xu J., Grewal I.S., Flavell R., Liu Y. CD40L is important for induction of, but not response to, costimulatory activity. ICAM-1 as the second costimulatory molecule rapidly up-regulated by CD40L. J Immunol. 157:1996;2764-2768.
8. Soong L., Duboise S.M., Kima P., McMahon-Pratt D. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect Immun. 63:1995;3559-3566.
9. Shu V., Kiniwa M., Wu C.Y., Maliszewski C., Verzio N., Hakimi J., Gately J.M., Delespesse G. Activated T cells induce interleukin 12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol. 25:1995;1125-1128.
10. Cella M., Scheidegger D., Palmer-Lehmann K., Lane P., Lanzavecchia A., Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med. 184:1996;747-752.
11. Kennedy M.K., Picha K.S., Fanslow K.H., Alderson M.R., Clifford K.N., Chin W.A., Mohler K.M. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol. 26:1996;370-378.
12. Koch F., Stanzl U., Jennewein P., Janke K., Heufler C., Kämpgen E., Romani N., Schuler G. High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med. 184:1996;741-746.
13. Stout R.D., Suttles J., Xu J., Grewal I.S., Flavell R.A. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol. 156:1996;8-11.
14. DeKruyff R.H., Gieni R.S., Umetsu D.T. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. J Immunol. 158:1997;359-366.
15. Durie F., Fava R., Foy T., Aruffo A., Ledbetter J., Noelle R. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science. 261:1993;1328-1330.
16. Buhlmann J.E., Noelle R.J. Therapeutic potential for the blockade of gp39-CD40 interaction. J Clin Immunol. 16:1996;83-87.
17. Zamvil S.S., Steinman L. The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol. 8:1990;579-621.
18. O'Garra A., Murphy K. T-cell subsets in autoimmunity. Curr Opin Immunol. 5:1993;880-886.
19. Trinchieri G. Interleukin-12 and its role in the generation of Th1 cells. Immunology Today. 14:1993;335.
20. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol. 13:1995;251-276.
21. Leonard J.P., Waldburger K.E., Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med. 81:1995;381-386.
22. Chen Y., Kuchroo V.K., Inobe J., Hafler D.A., Weiner H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 265:1994;1237-1240.
23. Cua D.J., Hinton D.R., Stohlman S.A. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J Immunol. 155:1995;4052-4059.
24. Gerritse K., Laman J.D., Noelle R., Aruffo A., Ledbetter J.A., Boersma W.J.A., Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA. 93:1996;2499-2504.
25. Samoilova E.B., Horton J.L., Zhang H., Chen Y. CD40L blockade prevents autoimmune encephalomyelitis and hampers Th1 but not Th2 pathway of T cell differentiation. J Mol Med. 75:1997;603-608.
26. Grewal I., Foellmer H.G., Grewal K.D., Xu J., Hardardottir F., Baron J.L., Janeway C.A.J., Flavell R.A. Requirement for CD40 Ligand in costimulation induction. T cell activation, and experimental allergic encephalomyelitis. Science. 273:1996;1864-1867.
27. Wysocka M., Kubin M., Vieira L., Ozmen L., Garotta G., Scott P., Trinchieri G. Interleukin-12 is required for interferon-γ production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol. 25:1995;672-676.
28. Frei K., Eugster H.-P., Bopst M., Constantinescu C.S., Lavi E., Fontana A. Tumor necrosis factor and lymphotoxin-α are not required for induction of acute experimental autoimmune encephalomyelitis. J Exp Med. 185:1997;2177-2182.
29. Foy T.M., Shepherd D.M., Durie F.H., Aruffo A., Ledbetter J.A. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J Exp Med. 178:1993;1567-1575.
30. Miller S.D., Vanderlugt C.L., Lenschow D.J., Pope J.G., Karandikar N.J., Dal Canto M.C., Bluestone J.A. Blockade of CD28/B7 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 3:1995;739-745.
31. Perrin P.J., Scott D., Quigley L., Albert P.S., Feder O., Gray G.S., Abe R., June C.H., Racke M.K. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol. 154:1995;1481-1490.
32. Murphy E., Terres G., Macatonia S., Hsieh C.-S., Mattson J., Lanier L., Wysocka M., Trinchieri G., Murphy K., O'Garra A. B7 and interleukin 12 cooperate for proliferation and interferon-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med. 180:1994;223-231.
33. Kubin M., Kamoun M., Trinchieri G. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells. J Exp Med. 180:1994;211-222.
34. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med. 172:1990;1193-1200.
35. Selmaj K., Raine C.S., Cross A.H. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol. 30:1991;694-700.
36. Stüber E., Strober W., Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin-12 secretion. J Exp Med. 183:1996;693-698.
37. Neurath M.F., Fuss I., Kelsall B.L., Stüber E., Strober W. Antibodies to interleukin-12 abrogate established experimental colitis in mice. J Exp Med. 183:1996;693-698.
38. Constantinescu C.S., Wysocka M., Hilliard B., Ventura E.S., Lavi E., Trinchieri G., Rostami A.M. Antibodies against Interleukin-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J Immunol. 161:1998;5097-5104.
39. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-718.
40. Balashov K.E., Smith D., Khoury S.J., Hafler D.A., Weiner H.L. Increased interleukin-12 production progressive in multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci USA. 94:1997;599-603.
41. Segall B., Dwyer B.K., Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med. 187:1998;537-546.
42. Issadeh S., Ljungdahl A., Hojeberg B., Mustafa M., Olsson T. Cytokine production in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis: dynamics of mRNA expression for interleukin-10, interleukin-12, cytolysin, tumor necrosis factor alpha and tumor necrosis factor beta. J Neuroimmunol. 61:1995;205-212.